Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2011

01.11.2011 | Epidemiology

Breast cancer risk assessment in women aged 70 and older

verfasst von: Pamela M. Vacek, Joan M. Skelly, Berta M. Geller

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Although the benefit of screening mammography for women over 69 has not been established, it is generally agreed that screening recommendations for older women should be individualized based on health status and breast cancer risk. However, statistical models to assess breast cancer risk have not been previously evaluated in this age group. In this study, the original Gail model and three more recent models that include mammographic breast density as a risk factor were applied to a cohort of 19,779 Vermont women aged 70 and older. Women were followed for an average of 7.1 years and 821 developed breast cancer. The predictive accuracy of each risk model was measured by its c-statistic and associations between individual risk factors and breast cancer risk were assessed by Cox regression. C-statistics were 0.54 (95% CI = 0.52–0.56) for the Gail model, 0.54 (95% CI = 0.51–0.56) for the Tice modification of the Gail model, 0.55 (95% CI = 0.53–0.58) for a model developed by Barlow and 0.55 (95% CI = 0.53–0.58) for a Vermont model. These results indicate that the models are not useful for assessing risk in women aged 70 and older. Several risk factors in the models were not significantly associated with outcome in the cohort, while others were significantly related to outcome but had smaller relative risks than estimated by the models. Age-related attenuation of the effects of some risk factors makes the prediction of breast cancer in older women particularly difficult.
Literatur
1.
Zurück zum Zitat Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (2002) SEER cancer statistics review, 1975–2007. National Cancer Institute, Bethesda Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (2002) SEER cancer statistics review, 1975–2007. National Cancer Institute, Bethesda
2.
Zurück zum Zitat Harrison RV, Janz NK, Wolfe RA, Tedeschi PJ, Huang X, McMahon LF Jr (2003) 5-Year mammography rates and associated factors for older women. Cancer 97:1147–1155PubMedCrossRef Harrison RV, Janz NK, Wolfe RA, Tedeschi PJ, Huang X, McMahon LF Jr (2003) 5-Year mammography rates and associated factors for older women. Cancer 97:1147–1155PubMedCrossRef
3.
Zurück zum Zitat Jerant AF, Franks P, Jackson JE, Doescher MP (2004) Age-related disparities in cancer screening: analysis of 2001 Behavioral Risk Factor Surveillance System data. Ann Fam Med 2:481–487PubMedCrossRef Jerant AF, Franks P, Jackson JE, Doescher MP (2004) Age-related disparities in cancer screening: analysis of 2001 Behavioral Risk Factor Surveillance System data. Ann Fam Med 2:481–487PubMedCrossRef
4.
Zurück zum Zitat Kagay CR, Quale C, Smith-Bindman R (2006) Screening mammography in the American elderly. Am J Prev Med 31:142–149PubMedCrossRef Kagay CR, Quale C, Smith-Bindman R (2006) Screening mammography in the American elderly. Am J Prev Med 31:142–149PubMedCrossRef
5.
Zurück zum Zitat McCarthy EP, Burns RB, Freund KM et al (2000) Mammography use, breast cancer stage at diagnosis, survival among older women. J Am Geriatr Soc 48:1226–1233PubMed McCarthy EP, Burns RB, Freund KM et al (2000) Mammography use, breast cancer stage at diagnosis, survival among older women. J Am Geriatr Soc 48:1226–1233PubMed
6.
Zurück zum Zitat Randolph WM, Goodwin JS, Mahnken JD, Freeman JL (2002) Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med 137:783–790PubMed Randolph WM, Goodwin JS, Mahnken JD, Freeman JL (2002) Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med 137:783–790PubMed
7.
Zurück zum Zitat Yancik R, Ries LG, Yates JW (1989) Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer 63:976–981PubMedCrossRef Yancik R, Ries LG, Yates JW (1989) Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer 63:976–981PubMedCrossRef
8.
Zurück zum Zitat U.S. Preventive Services Task Force (2009) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151:716–726, W-236 U.S. Preventive Services Task Force (2009) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151:716–726, W-236
9.
Zurück zum Zitat Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP (2003) American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 53:141–169PubMedCrossRef Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP (2003) American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 53:141–169PubMedCrossRef
10.
Zurück zum Zitat American Geriatric Society Clinical Practice Committee (2000) Breast cancer screening in older women: AGS position statement. J Am Geriatr Soc 48:842–844 American Geriatric Society Clinical Practice Committee (2000) Breast cancer screening in older women: AGS position statement. J Am Geriatr Soc 48:842–844
11.
Zurück zum Zitat Takahashi PY, Okhravi HR, Lim LS, Kasten MJ (2004) Preventive health care in the elderly population: a guide for practicing physicians. Mayo Clin Proc 79:416–427PubMedCrossRef Takahashi PY, Okhravi HR, Lim LS, Kasten MJ (2004) Preventive health care in the elderly population: a guide for practicing physicians. Mayo Clin Proc 79:416–427PubMedCrossRef
12.
Zurück zum Zitat Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Shairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886PubMedCrossRef Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Shairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886PubMedCrossRef
13.
Zurück zum Zitat Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541–1548PubMedCrossRef Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541–1548PubMedCrossRef
14.
Zurück zum Zitat McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169PubMedCrossRef McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169PubMedCrossRef
15.
Zurück zum Zitat Benichou J, Byrne C, Capece LA, Carroll LE, Hurt-Mullen K, Pee DY, Salane M, Schairer C, Gail MH (2003) Secular stability and reliability of measurements of the percentage of dense tissue on mammograms. Cancer Detect Prev 27:266–274PubMedCrossRef Benichou J, Byrne C, Capece LA, Carroll LE, Hurt-Mullen K, Pee DY, Salane M, Schairer C, Gail MH (2003) Secular stability and reliability of measurements of the percentage of dense tissue on mammograms. Cancer Detect Prev 27:266–274PubMedCrossRef
16.
Zurück zum Zitat Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, Benichou J, Gail MH (2006) Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 98:1215–1226PubMedCrossRef Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, Benichou J, Gail MH (2006) Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 98:1215–1226PubMedCrossRef
17.
Zurück zum Zitat American College of Radiology (ACR) (2003) Breast imaging reporting and data system, 4th edn. American College of Radiology, Reston, Virginia American College of Radiology (ACR) (2003) Breast imaging reporting and data system, 4th edn. American College of Radiology, Reston, Virginia
18.
Zurück zum Zitat Tice JA, Cummings SR, Ziv E, Kerlikowske K (2005) Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94:115–122PubMedCrossRef Tice JA, Cummings SR, Ziv E, Kerlikowske K (2005) Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94:115–122PubMedCrossRef
19.
Zurück zum Zitat Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA et al (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98:1204–1214PubMedCrossRef Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA et al (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98:1204–1214PubMedCrossRef
20.
Zurück zum Zitat Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA ((2001)) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358–366CrossRef Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA ((2001)) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358–366CrossRef
21.
Zurück zum Zitat Spiegelman D, Colditz GA, Hunter D, Hertzmark E (1994) Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 86:600–607PubMedCrossRef Spiegelman D, Colditz GA, Hunter D, Hertzmark E (1994) Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 86:600–607PubMedCrossRef
22.
Zurück zum Zitat Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807–814PubMedCrossRef Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807–814PubMedCrossRef
23.
Zurück zum Zitat Kaur JS, Roubidoux MA, Sloan J, Novotny P (2004) Can the Gail model be useful in American Indian and Alaska Native populations? Cancer 100:906–912PubMedCrossRef Kaur JS, Roubidoux MA, Sloan J, Novotny P (2004) Can the Gail model be useful in American Indian and Alaska Native populations? Cancer 100:906–912PubMedCrossRef
24.
Zurück zum Zitat MacKarem G, Roche CA, Hughes KS (2001) The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age. Breast J 7:34–39PubMedCrossRef MacKarem G, Roche CA, Hughes KS (2001) The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age. Breast J 7:34–39PubMedCrossRef
25.
Zurück zum Zitat Vacek PM, Geller BM (2004) A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 13:715–722PubMed Vacek PM, Geller BM (2004) A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 13:715–722PubMed
26.
Zurück zum Zitat Geller BM, Worden JK, Ashley JA, Oppenheimer RG, Weaver DL (1996) Multipurpose statewide breast cancer surveillance system: the Vermont experience. J Regist Manag 23:168–174 Geller BM, Worden JK, Ashley JA, Oppenheimer RG, Weaver DL (1996) Multipurpose statewide breast cancer surveillance system: the Vermont experience. J Regist Manag 23:168–174
27.
Zurück zum Zitat Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA et al (1997) Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169:1001–1008PubMed Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA et al (1997) Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169:1001–1008PubMed
28.
Zurück zum Zitat McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA et al (2009) Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 27:5893–5898PubMedCrossRef McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA et al (2009) Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 27:5893–5898PubMedCrossRef
29.
Zurück zum Zitat Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: a collaborative reanalysis of individual data form 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 358:1389–1399CrossRef Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: a collaborative reanalysis of individual data form 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 358:1389–1399CrossRef
30.
Zurück zum Zitat van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514–527PubMedCrossRef van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514–527PubMedCrossRef
31.
Zurück zum Zitat Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053PubMed Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053PubMed
32.
Zurück zum Zitat Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99:386–395PubMedCrossRef Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R (2007) Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 99:386–395PubMedCrossRef
33.
Zurück zum Zitat van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Straatman H, Verbeek AL (1999) Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev 8:509–515PubMedCrossRef van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Straatman H, Verbeek AL (1999) Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev 8:509–515PubMedCrossRef
34.
Zurück zum Zitat Abramson RG, Mavi A, Cermik T, Basu S, Wehrli NE, Houseni M et al (2007) Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography. Semin Nucl Med 37:146–153PubMedCrossRef Abramson RG, Mavi A, Cermik T, Basu S, Wehrli NE, Houseni M et al (2007) Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography. Semin Nucl Med 37:146–153PubMedCrossRef
35.
Zurück zum Zitat Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM et al (2008) Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 26:5374–5379PubMedCrossRef Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM et al (2008) Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 26:5374–5379PubMedCrossRef
36.
Zurück zum Zitat Gail M, Rimer B (1998) Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 16:3105–3114PubMed Gail M, Rimer B (1998) Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 16:3105–3114PubMed
37.
Zurück zum Zitat Kerlikowske K (2009) Evidence-based breast cancer prevention: the importance of individual risk. Ann Intern Med 151:750–752PubMed Kerlikowske K (2009) Evidence-based breast cancer prevention: the importance of individual risk. Ann Intern Med 151:750–752PubMed
38.
Zurück zum Zitat Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285:2750–2756PubMedCrossRef Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285:2750–2756PubMedCrossRef
Metadaten
Titel
Breast cancer risk assessment in women aged 70 and older
verfasst von
Pamela M. Vacek
Joan M. Skelly
Berta M. Geller
Publikationsdatum
01.11.2011
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2011
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1576-1

Weitere Artikel der Ausgabe 1/2011

Breast Cancer Research and Treatment 1/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.